Motus GI Holdings, Inc. (MOTS) vs Nuwellis, Inc. (NUWE)

Motus GI Holdings, Inc. and Nuwellis, Inc. are both Medical Devices companies. Nuwellis, Inc. is the larger, with a market value of $2.0M against $420.0K — 4.8× the size. Nuwellis, Inc. grew revenue faster over the last twelve months: 8.36% against −47.9%. Nuwellis, Inc. has the higher net margin (−125.6% vs −4,924.2%) and the higher return on invested capital (0.00% vs −1,411.3%). Across the 16 metrics below, Nuwellis, Inc. leads on 12 and Motus GI Holdings, Inc. on 4.

Valuation

Metric MOTS NUWE Medical Devices median
P/E n/m n/m 23.22
P/S n/m 0.01 2.34
P/B n/m n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 0.30 n/m 11.54
EV/Sales (8.08) 0.01 2.24
Earnings yield 0.00% (24,106.36%) (10.09%)
Free cash flow yield 0.00% (12,722.26%) (8.47%)

Profitability

Metric MOTS NUWE Medical Devices median
Gross margin (24.46%) 69.69% 56.01%
Operating margin (2,927.83%) (142.87%) (15.03%)
Net margin (4,924.16%) (125.57%) (20.40%)
Free cash flow margin (2,573.39%) (140.67%) (7.24%)
Return on equity (1,624.82%) 205.50% (15.32%)
Return on assets (166.89%) (123.52%) (19.72%)
Return on invested capital (1,411.26%) 0.00% (10.33%)

Growth

Metric MOTS NUWE Medical Devices median
Revenue growth (TTM) (47.93%) 8.36% 8.80%
EPS growth (last fiscal year) 81.54% 92.81% 29.03%
Revenue growth, 5-year CAGR 54.70% 2.14% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MOTS NUWE Medical Devices median
Debt to equity 0.75 0.00 0.07
Current ratio 1.74 1.97 2.50
Net debt to EBITDA 0.24 0.10 0.49

Dividend

Metric MOTS NUWE Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric MOTS NUWE Medical Devices median
Market cap 420.00k 2.01m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack